v2.3.0.11
Acquisition of King Pharmaceuticals, Inc. Narrative (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jul. 03, 2011
Jul. 04, 2010
Jul. 03, 2011
Jul. 04, 2010
Jul. 03, 2011
King [Member]
Feb. 28, 2011
King [Member]
Jan. 31, 2011
King [Member]
Jul. 04, 2010
King [Member]
Pro Forma Consolidated Results [Member]
Jul. 03, 2011
King [Member]
Pro Forma Consolidated Results [Member]
Jul. 04, 2010
King [Member]
Pro Forma Consolidated Results [Member]
Business Acquisition [Line Items]                    
Acquisition purchase price per share           $ 14.25 $ 14.25      
Percent of outstanding shares initially acquired             92.50%      
Payments to acquire businesses, net of cash acquired     $ 3,169   $ 3,169          
Gross contractual amount receivable             200      
Elimination of intangible asset amortization               38 6 79
Additional amortization of intangible assets               43   86
Additional depreciation expense               9 3 17
Purchase accounting adjustment for estimated sales of acquisition-date inventory at fair value 3,805 [1] 3,684 [1] 7,498 [1] 7,886 [1]       61 (119) 119
Adjustment for acquisition-related costs               $ 63 $ (181) $ 181
[1] Exclusive of amortization of intangible assets, except as disclosed in Note 11B. Goodwill and Other Intangible Assets: Other Intangible Assets.